Literature DB >> 7774046

Inhibition of gene expression by anti-sense oligodeoxynucleotides.

R Q Zheng, D M Kemeny.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7774046      PMCID: PMC1534473          DOI: 10.1111/j.1365-2249.1995.tb03709.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  28 in total

1.  RNA substrate binding site in the catalytic core of the Tetrahymena ribozyme.

Authors:  A M Pyle; F L Murphy; T R Cech
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

2.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  Systemic human antisense therapy begins.

Authors:  E Bayever; P Iversen; L Smith; J Spinolo; G Zon
Journal:  Antisense Res Dev       Date:  1992

4.  Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region.

Authors:  T A Bacon; E Wickstrom
Journal:  Oncogene Res       Date:  1991

Review 5.  Parallel DNA triplexes, homologous recombination, and other homology-dependent DNA interactions.

Authors:  R D Camerini-Otero; P Hsieh
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

6.  Synthesis, hybridization properties and antiviral activity of lipid-oligodeoxynucleotide conjugates.

Authors:  R G Shea; J C Marsters; N Bischofberger
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

7.  Electron microscopy visualization of oligonucleotide binding to duplex DNA via triplex formation.

Authors:  D I Cherny; V A Malkov; A A Volodin; M D Frank-Kamenetskii
Journal:  J Mol Biol       Date:  1993-03-20       Impact factor: 5.469

8.  Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells.

Authors:  T L Fisher; T Terhorst; X Cao; R W Wagner
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

Review 9.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

10.  Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats.

Authors:  N Benbernou; P Matsiota-Bernard; M Guenounou
Journal:  Eur J Immunol       Date:  1993-03       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.